20th December 2016

U.S. Roller Hockey Athlete, Mazzie, Accepts Sanction for ADRV

USADA announced today that Joseph Mazzie, of East Meadow, N.Y., an athlete in the sport of roller hockey, has tested positive for a prohibited substance and accepted a four-year suspension for his violation. Mazzie, 29, tested positive for RAD140 and ibutamoren as the result of an out-of-competition urine sample he provided on August 24, 2016.

RAD140 is a substance in the class of Anabolic Agents, while ibutamoren is in the class of Peptide Hormones, Growth Factors, Related Substances and Mimetics. Both substances are prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the International Roller Sports Federation Anti-Doping Policy, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.

The use of experimental drugs like RAD140 and ibutamoren by athletes and consumers poses serious health risks, and these drugs are not approved by the FDA for human use or consumption. Mazzie’s period of ineligibility began on August 24, 2016, the date his positive sample was collected. In addition, Mazzie has been disqualified from all competitive results obtained on and subsequent to August 24, 2016, including forfeiture of any medals, points and prizes.

• This media release was originally published by the US Anti-Doping Agency (USADA) on 20 December 2016. To access the original, please click here.

You may also like...

Pin It on Pinterest

Share This